Publication Cover
Mycology
An International Journal on Fungal Biology
Volume 14, 2023 - Issue 4
609
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Mycotoxins from Alternaria panax, the specific plant pathogen of Panax ginseng

, , , , , , , & show all
Pages 381-392 | Received 04 Jun 2023, Accepted 27 Sep 2023, Published online: 01 Nov 2023
 

ABSTRACT

Ginseng black spot, caused by Alternaria panax, is one of the most common diseases of Panax ginseng, which usually causes serious yield loss of ginseng plants. However, the pathogenic mechanism of A. panax has not been clarified clearly. Mycotoxins produced by phytopathogens play an important role in the process of infection. Previous study reported that dibutyl phthalate (DBP) identified from the metabolites of A. panax is a potent mycotoxin against P. ginseng. However, more evidence suggests that DBP is one of the constituents of plasticisers. To identify mycotoxins from A. panax and evaluate their phytotoxicity on the leaves of P. ginseng, different chromatographic, spectral and bioassay-guided methods were used together in this report. As a result, tyrosol (1), 3-hydroxy-3-(4-methoxyphenyl) propanoic acid (2), and 3-benzylpiperazine-2,5-dione (3) were isolated and characterised from the extract of A. panax, in which compounds 1 and 2 showed phytotoxic activity on ginseng leaves. Furthermore, DBP was confirmed to come from the residue of ethyl acetate through UPLC-MS/MS analysis, and displayed no phytotoxicity on ginseng leaves based on biological experiments. The results in this report first revealed that tyrosol (1), and 3-hydroxy-3-(4-methoxyphenyl) propanoic acid (2) not DBP were the potent mycotoxins of A. panax.

Disclosure statement

No potential conflict of interest was reported by the authors.

Correction Statement

This article has been corrected with minor changes. These changes do not impact the academic content of the article.

Additional information

Funding

This work was supported by the Ability Establishment of Sustainable Use for Valuable Chinese Medicine Resources (2060302-2101-18), the CAMS Innovation Fund for Medical Sciences (2021-I2M-1-032), National Key Research and Development Program of China (2017YFC1700701, 2020YFC1712700), and the National Project for Agricultural Technology System (CARS-21).